COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,786 Articles (22,946 medRxiv, 8,840 bioRxiv)

Most recent first Previous |  Page 591: Articles 5901-5910  | Next

The Effect of the COVID-19 Pandemic on Life Expectancy in the US: An Application of Hybrid Life Expectancy
Sanderson, W. C., Scherbov, S.
10.1101/2022.12.19.22283697 — Posted: 2022-12-20
Systematic review: Longitudinal effects of the COVID-19 pandemic on child and adolescent mental health
Wolf, K., Schmitz, J.
10.1101/2022.12.20.22283720 — Posted: 2022-12-20
Impact of Age, Race, and Family History on COVID-19 Related Changes in Breast Cancer Screening among the Boston Mammography Cohort Study
Chen, N., Cheng, D., Sodipo, M. O., Barnard, M. E., DuPre, N. C., Tamimi, R., Warner, E. T.
10.1101/2022.12.20.22283719 — Posted: 2022-12-20
Impact of guidance on trends of steroid prescriptions for COVID-19 inpatients: an analysis of the nation-wide administrative database in Japan
Higuchi, T., Shin, J.-h., Takada, D., Morishita, T., Kunisawa, S., Imanaka, Y.
10.1101/2022.12.20.22283717 — Posted: 2022-12-20
SARS-CoV-2 mRNA vaccination exposes progressive adaptive immune dysfunction in patients with chronic lymphocytic leukemia
Qin, K., Honjo, K., Sherrill-Mix, S., Liu, W., Stoltz, R. M., Oman, A. K., Hall, L. A., Li, R., Sterrett, S., Frederick, E. R., Lancaster, J. R., Narkhede, M., Mehta, A., Ogunsile, F. J., Patel, R. B., Ketas, T. J., Cruz Portillo, V. M., Cupo, A., Larimer, B. M., Bansal, A., Goepfert, P. A., Hahn, B. H., Davis, R. S.
10.1101/2022.12.19.22283645 — Posted: 2022-12-20
Antidepressant drug prescription and incidence of COVID-19: a retrospective cohort study
Glebov, O. O., Mueller, C., Stewart, R., Aarsland, D., Perera, G.
10.1101/2022.12.15.22283507 — Posted: 2022-12-20
A prospective evaluation of three saliva qualitative antigen testing kits for the detection of SARS-CoV-2 in Japan
Terada, N., Akashi, Y., Takeuchi, Y., Ueda, A., Notake, S., Nakamura, K., Suzuki, H.
10.1101/2022.12.18.22281291 — Posted: 2022-12-20
The onset of late severe lung impairment in COVID-19 is associated with high inflammation markers at admission and metabolic syndrome markers
EPAULARD, O., LE GOUELLEC, A., LE MARECHAL, M., NEMOZ, B., BOREL, A. L., DARTEVEL, A., GHEERBRANT, H., HERAULT, M. C., BOSSERAY, A., CLAVARINO, G., LUPO, J., VIGLINO, D., QUENARD, F., CANDILLE, C., CAMARA, B., DURAND, M., FAURE, P., GUERGOUR, D., CHIDLOVSKI, E., JACOB, M. C., LARRAT, S., FROIDURE, M., TERZI, N., QUETANT, S., PAYEN, J. F., COLOMBE, B., RASKOVALOVA, T., MORAND, P., PIERRE, I., SCHWEBEL, C., HAMIDFAR, R., BOUILLET, L., BRION, J. P., TROCME, C., BERTHIER, S., CHIRICA, C., MOUNAYAR, A. L., BLANC, M., PAVESE, P., TOUSSAINT, B.
10.1101/2022.12.20.22282909 — Posted: 2022-12-20
Tracking the COVID-19 vaccine equity, distribution, and cases in the global south
Melesse, T. M.
10.1101/2022.12.19.22283681 — Posted: 2022-12-20
Modeling a traffic light warning system for acute respiratory infections
Diaz-Infante, S., Acuna-Zegarra, M. A., Velasco-Hernandez, J. X.
10.1101/2022.12.16.22283591 — Posted: 2022-12-20

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).